De-escalating Breast Cancer Surgery-Where Is the Tipping Point?

被引：17
|
作者：
Morrow, Monica [1 ]
Winer, Eric P. [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, 300 E 66th St, New York, NY 10065 USA
[2] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
来源：
JAMA ONCOLOGY | 2020年 / 6卷 / 02期
关键词：
SURVIVAL; THERAPY; WOMEN;
D O I：
10.1001/jamaoncol.2019.4849
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This Viewpoint provides a perspective on recent trials focused on reducing the incidence of surgery in the treatment of breast cancer.
引用
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [41] De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
    Curigliano, G.
    Burstein, H. J.
    Winer, E. P.
    Gnant, M.
    Dubsky, P.
    Loibl, S.
    Colleoni, M.
    Regan, M. M.
    Piccart-Gebhart, M.
    Senn, H. -J.
    Thurlimann, B.
    Andre, F.
    Baselga, J.
    Bergh, J.
    Bonnefoi, H.
    Brucker, S. Y.
    Cardoso, F.
    Carey, L.
    Ciruelos, E.
    Cuzick, J.
    Denkert, C.
    Di Leo, A.
    Ejlertsen, B.
    Francis, P.
    Galimberti, V.
    Garber, J.
    Gulluoglu, B.
    Goodwin, P.
    Harbeck, N.
    Hayes, D. F.
    Huang, C. -S.
    Huober, J.
    Khaled, H.
    Jassem, J.
    Jiang, Z.
    Karlsson, P.
    Morrow, M.
    Orecchia, R.
    Osborne, K. C.
    Pagani, O.
    Partridge, A. H.
    Pritchard, K.
    Ro, J.
    Rutgers, E. J. T.
    Sedlmayer, F.
    Semiglazov, V.
    Shao, Z.
    Smith, I.
    Toi, M.
    Tutt, A.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 1700 - 1712
  • [42] Role of the Surgeon in De-Escalating Emotion During a Breast Cancer Surgery Consultation: A Qualitative Study of Patients' Experiences in Alliance A231701CD
    Saucke, Megan C.
    Jacobson, Nora
    McKinney, Grace
    Neuman, Heather B.
    ANNALS OF SURGICAL ONCOLOGY, 2024, : 8873 - 8881
  • [43] De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study
    Annemiek K. E. van Hemert
    Josefien P. van Olmen
    Liesbeth J. Boersma
    John H. Maduro
    Nicola S. Russell
    Jolien Tol
    Ellen G. Engelhardt
    Emiel J. Th. Rutgers
    Marie-Jeanne T. F. D. Vrancken Peeters
    Frederieke H. van Duijnhoven
    Breast Cancer Research and Treatment, 2023, 199 : 81 - 89
  • [44] De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study
    van Hemert, Annemiek K. E.
    van Olmen, Josefien P. P.
    Boersma, Liesbeth J. J.
    Maduro, John H. H.
    Russell, Nicola S. S.
    Tol, Jolien
    Engelhardt, Ellen G. G.
    Rutgers, Emiel J. Th.
    Peeters, Marie-Jeanne T. F. D. Vrancken
    van Duijnhoven, Frederieke H. H.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 199 (01) : 81 - 89
  • [45] Is There a Place for De-escalating Therapy in Patients with Metastatic Hormone-sensitive Prostate Cancer?
    Turco, Fabio
    Tombal, Bertrand
    Gillessen, Silke
    Omlin, Aurelius
    EUROPEAN UROLOGY FOCUS, 2024, 10 (04): : 518 - 521
  • [46] The changing role of gene-expression profiling in the era of de-escalating adjuvant chemotherapy in early stage breast cancer
    Steenhoven, J. V.
    Kuijer, A.
    Schreuder, K.
    Elias, S.
    Diest, P. V.
    Wall, E. V. D.
    Siesling, S.
    Dalen, T. V.
    ANNALS OF ONCOLOGY, 2019, 30
  • [47] De-escalating axillary management after neoadjuvant chemotherapy in breast cancer: The ratio of positive sentinel lymph nodes matters
    Aragon-Sanchez, S.
    Sanchez-Bayona, R.
    Lopez-Marin, L.
    Ciruelos-Gil, E.
    Parrilla-Rubio, L.
    Zaragoza-Ballester, Pablo
    Galindo-Izquierdo, A.
    Garcia-Chapinal, B.
    Alvaro-Valiente, L.
    Oliver-Perez, M. R.
    SURGICAL ONCOLOGY-OXFORD, 2024, 54
  • [48] Feasibility of de-escalating axillary surgery in patients with clinical N2–3, pathological N0 breast cancer after neoadjuvant chemotherapy
    Ee Jin Kim
    Tae Kyung Yoo
    Jisun Kim
    Il Yong Chung
    Beom Seok Ko
    Hee Jeong Kim
    Jong Won Lee
    Byung Ho Son
    Sae Byul Lee
    Scientific Reports, 15 (1)
  • [49] The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer
    van Steenhoven, J. E. C.
    Kuijer, A.
    Schreuder, K.
    Elias, S. G.
    van Diest, P. J.
    van der Wall, E.
    Siesling, S.
    van Dalen, T.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (11) : 3495 - 3501
  • [50] The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer
    J. E. C. van Steenhoven
    A. Kuijer
    K. Schreuder
    S. G. Elias
    P. J. van Diest
    E. van der Wall
    S. Siesling
    T. van Dalen
    Annals of Surgical Oncology, 2019, 26 : 3495 - 3501
12345